SETOMPLA Trademark

Trademark Overview

On Tuesday, June 3, 2008, a trademark application was filed for SETOMPLA with the United States Patent and Trademark Office. The USPTO has given the SETOMPLA trademark a serial number of 77489892. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 19, 2011. This trademark is owned by AstraZeneca AB. The SETOMPLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
setompla

General Information

Serial Number77489892
Word MarkSETOMPLA
Filing DateTuesday, June 3, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 19, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
Translation of Words in MarkThe wording "SETOMPLA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 9, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Tuesday, April 19, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 19, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 20, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 20, 2010INQUIRY TO SUSPENSION E-MAILED
Monday, September 20, 2010SUSPENSION INQUIRY WRITTEN
Thursday, March 18, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 15, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, September 15, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 15, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 12, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009SUSPENSION LETTER WRITTEN
Thursday, March 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, March 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, March 12, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, March 9, 2009EXAMINER'S AMENDMENT ENTERED
Monday, March 9, 2009ASSIGNED TO LIE
Friday, March 6, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2009EXAMINERS AMENDMENT -WRITTEN
Sunday, September 14, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 14, 2008NON-FINAL ACTION E-MAILED
Sunday, September 14, 2008NON-FINAL ACTION WRITTEN
Friday, September 12, 2008ASSIGNED TO EXAMINER
Monday, June 9, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

setompla pharmaceutical treatment preparations disorders diseases diabetes cancer neurological infection psychiatric